This GLP-1 Stock's Bad News Could Be a Big Win for Eli Lilly and Novo Nordisk
2/7 03:14
There are a lot of healthcare companies that are investing in GLP-1 weight loss drugs. Today, the leaders in that space are Eli Lilly and Novo Nordisk. But it could get much more crowded in the future. And it's little wonder why, given analysts project that the obesity drug marke...